ライフサイエンスコーパス: weekly

1 cetuximab (400 mg/m2 on day 1 then 250 mg/m2 weekly).

2 3 weeks or intravenous paclitaxel 80 mg/m(2) weekly).

3 aintenance dosing (initial dose 0.6 mg/kg IV weekly).

4 e at a dose of 2 mg or matching placebo once weekly.

5 f each 28-day cycle, and dexamethasone 40 mg weekly.

6 g daily for 21 days, and dexamethasone 40 mg weekly.

7 cytomegalovirus (CMV), and BK virus screened weekly.

8 UV-B light, 3x/week, and tumors were tracked weekly.

9 (80 mg) plus 20 mg dexamethasone given twice weekly.

10 nd mean severity scores were recorded thrice weekly.

11 icipants (1:1:1) to either subcutaneous once-weekly 0.5 mg or 1.0 mg semaglutide (doses reached after

12 lternative to the currently recommended once weekly 0.75 mg/kg regimen for G6PDd.

13 tarting at week 1, or oral methotrexate once weekly (0.1-0.4 mg/kg) for 16 weeks.

14 ients in the group that received tocilizumab weekly, 14% of those in the group that received tocilizu

15 ecombinant human C1 esterase inhibitor twice weekly (2.7 attacks [SD 2.4]) and once weekly (4.4 attac

16 CAM2038 weekly, 24 and 32 mg, was safely tolerated and produced

17 twice weekly (2.7 attacks [SD 2.4]) and once weekly (4.4 attacks [3.2]) versus placebo (7.2 attacks [

18 The BBT consisted of 8 to 12 weekly 45-minute sessions of behavioral therapy delivere

19 eiving weekly adalimumab and azathioprine or weekly adalimumab alone if failure criteria were not met

20 calation was possible for patients receiving weekly adalimumab and azathioprine or weekly adalimumab

21 k, adalimumab every week, and lastly to both weekly adalimumab and daily azathioprine.

22 e, we recommend a dose for future studies of weekly ADI-PEG 20 36 mg/m(2) plus three-weekly cisplatin

23 ive patients (five MPM, four NSCLC) received weekly ADI-PEG 20 doses of 18 mg/m(2), 27 mg/m(2), or 36

24 ER2-neu antibodies, all loaded with PTX were weekly administrated intravenously.

25 Weekly administration from 5 to 11 weeks of age prevente

26 Weekly administration of bortezomib enhanced tolerabilit

27 Weekly administration of PF-06747143 to leukemic mice si

28 rexate-induced gastrointestinal AEs than did weekly administration.

29 , the lifestyle intervention included 5 to 6 weekly aerobic training sessions (duration 30-60 minutes

30 21 days), either with cetuximab (250 mg/m(2) weekly after loading dose; cetuximab group) or without (

31 er exacerbation history in patients in the 4-weekly and 8-weekly benralizumab groups.

32 .7-9.5) with trastuzumab emtansine 2.4 mg/kg weekly and 8.6 months (7.1-11.2) with taxane treatment (

33 d to receive trastuzumab emtansine 2.4 mg/kg weekly and a further 80 to receive a taxane.

34 nt reports, and clinician reports as well as weekly and discharge Family Safety Interviews (FSIs).

35 56% of the patients treated with tocilizumab weekly and in 53% of those treated with tocilizumab ever

36 recombinant human C1 esterase inhibitor once weekly and placebo once weekly, and placebo twice weekly

37 Across all 3 levels of salt intake, half-weekly and weekly rhythmical mineralocorticoid release p

38 ir blood glucose levels daily, 15% monitored weekly, and 10% reported checking their blood pressure d

39 5 to receive trastuzumab emtansine 2.4 mg/kg weekly, and 37 to receive a taxane in the stage 1 part o

40 ear 10 for belatacept 4-weekly, belatacept 8-weekly, and cyclosporine were 11.1%, 21.9%, and 13.9%, r

41 ear 10 for belatacept 4-weekly, belatacept 8-weekly, and cyclosporine were 67.0, 68.7, and 42.7 mL/mi

42 erase inhibitor once weekly and placebo once weekly, and placebo twice weekly, each for 4 weeks with

43 DMC selected trastuzumab emtansine 2.4 mg/kg weekly as the dose to proceed to stage 2.

44 Treatment with adalimumab (40 mg weekly), as compared with placebo, resulted in significa

45 rticipants were randomized to either CAM2038 weekly at 24 mg (n = 22) or 32 mg (n = 25); the assigned

46 therapy received labetuzumab govitecan once weekly at 8 and 10 mg/kg, or two times per week at 4 and

47 K9 levels were measured at baseline and then weekly at weeks 8 through 12.

48 ctions of fitusiran administered either once weekly (at a dose of 0.015, 0.045, or 0.075 mg per kilog

49 he latest two Immune Epitope Database (IEDB) weekly automated benchmark datasets.

50 In this cohort study, we sampled on a weekly basis 132 3-week old pigs for 15 weeks.

51 the deutetrabenazine dose was titrated on a weekly basis for optimal chorea control.

52 d therapeutic foods on a monthly rather than weekly basis, may be one alternative.We aimed to describ

53 web services and data that are updated on a weekly basis.

54 nd randomization to year 10 for belatacept 4-weekly, belatacept 8-weekly, and cyclosporine were 11.1%

55 mean GFR values at year 10 for belatacept 4-weekly, belatacept 8-weekly, and cyclosporine were 67.0,

56 on history in patients in the 4-weekly and 8-weekly benralizumab groups.

57 eived 2 (cohort 1) or 3 (cohort 2) cycles of weekly BV; PET-negative patients (Deauville score </=2)

58 r allogeneic stem cell transplantation twice weekly by use of a commercial GM enzyme-linked immunosor

59 Both weekly CAM2038 doses produced immediate and sustained bl

60 , any illicit drug use (1.72, 1.07-2.79) and weekly cannabis use (3.18, 1.58-6.42).

61 emaining associations, with the exception of weekly cannabis use at age 35 years, which remained inde

62 any amphetamine use to 3.39 (3.12-3.67) for weekly cannabis use; for dependence syndrome they were 1

63 Medically fit patients received concurrent weekly carboplatin plus paclitaxel followed by 3 cycles

64 randomised to monitoring with or without 12-weekly CD4 counts and to receive 2 nucleoside reverse tr

65 rnover of plant-pollinator interactions from weekly censuses across 3 years in a subalpine ecosystem.

66 of 50.4 Gy/1.8 Gy fractions with or without weekly cetuximab (400 mg/m2 on day 1 then 250 mg/m2 week

67 odulated radiation therapy (IMRT) 54 Gy with weekly cetuximab; those with less than cCR to IC at the

68 Weekly change in inner and outer retinal thickness and p

69 s of weekly ADI-PEG 20 36 mg/m(2) plus three-weekly cisplatin 75 mg/m(2) and pemetrexed 500 mg/m(2).

70 (2) selinexor plus 20 mg dexamethasone twice weekly cohort (ORR = 50%).

71 Patients were randomized to weekly concurrent cisplatin (50 mg/m2), paclitaxel (25 m

72 asonal influenza calibrated to 14 seasons of weekly consultation and virology data in England and Wal

73 utable harms, including after adjustment for weekly consumption, binge drinking, BMI, and smoking.

74 oughout, daily (intensive phase) then thrice weekly (continuation phase), and daily (intensive phase)

75 ase), and daily (intensive phase) then twice weekly (continuation phase).

76 Weekly conversion rates were not significantly different

77 We assume that weekly counts for the number of new diagnosed cases are

78 Average weekly CRTE proportions from weeks 5-12 were significant

79 R 162-399) at a rate of 38 (IQR 34-42) per 4-weekly cycle.

80 hronic sleep restriction in the lab (i.e., 3 weekly cycles of 5 nights of 4 hours of sleep per night

81 les of cisplatin and fluorouracil (CF; two 3-weekly cycles of cisplatin [80 mg/m(2) intravenously on

82 in, cisplatin, and capecitabine (ECX; four 3-weekly cycles of epirubicin [50 mg/m(2)] and cisplatin [

83 signed (1:1) to standard chemotherapy (six 3-weekly cycles of paclitaxel [175 mg/m(2) of body surface

84 ic acid (ZA) 4 mg was administered for six 3-weekly cycles, then 4-weekly for 2 years.

85 Using weekly data from western Lake Erie in 2014, we investiga

86 B) contributed data for at least half of the weekly data points, and 93.2% and 88.7% contributed to a

87 ts demonstrated specific tolerance to 8 more weekly donor transfusions that had not been treated.

88 e-weekly folic acid, regardless of the total weekly dosage.

89 After a 2-week lead-in with weekly dose escalation, daily venetoclax was given at 30

90 The two once-weekly dose schedules, showing comparable toxicity and e

91 /tolerability and CP-blocking potential of 4 weekly doses (60 mg/kg) of the anti-C1s antibody BIVV009

92 mor and regional lymph nodes plus eight once-weekly doses of concurrent cetuximab and two cycles of c

93 al lymph nodes (45 to 54 Gy) plus eight once-weekly doses of concurrent cetuximab.

94 ocetaxel, prednisone, and custirsen received weekly doses of custirsen 640 mg intravenously after thr

95 ewest latent tuberculosis (LTBI) regimen, 12 weekly doses of directly observed isoniazid and rifapent

96 for single-dose (177)Lu-DOTATATE, 35 d for 3 weekly doses of GMX1778, and 98 d for combined treatment

97 After (177)Lu-DOTATATE and 3 weekly doses of GMX1778, none of the tumors progressed w

98 itis (n=42) were randomized to receive eight weekly doses of i.n.

99 uppression reduction, were treated with four weekly doses of rituximab induction.

100 These studies have used repeated high weekly doses of various tau antibodies administered syst

101 Four weekly doses persistently blocked complement for 5 to 6

102 usually involves once-daily dosing, although weekly dosing in children has been suggested for its red

103 weekly dosing throughout therapy, and twice weekly dosing in the continuation phase appear to have w

104 The effects of daily or weekly dosing require further study.

105 entrations and dose scheduling showed that a weekly dosing schedule of 4mg SN-38/kg was the most effi

106 Six patients were treated with the initial weekly dosing scheme; 2 of these patients died of neutro

107 Thrice weekly dosing throughout therapy, and twice weekly dosin

108 e, because both the weekly frequency and the weekly duration of exercise time are an order of magnitu

109 valuations performed at screening, baseline, weekly during admission, on discharge, and after 90 days

110 ycles, and intravenous rituximab 375 mg/m(2) weekly during cycle 1.

111 79 vaginal swabs collected prospectively and weekly during gestation using 16S rRNA gene sequencing.

112 ice weekly in part 1 of reSURFACE 2 and once weekly during part 2).

113 Patients were assessed weekly during treatment.

114 y and placebo once weekly, and placebo twice weekly, each for 4 weeks with a 1 week washout period be

115 The attention control consisted of weekly educational lectures by clinicians for 6 months.

116 tially completed 11 internet modules and had weekly email contacts.

117 rmittent dosing of prednisone, provided once weekly, enhanced muscle repair and did not induce atroph

118 We use weekly estimates of diurnal occurrence and relative abun

119 telomere length were associated with average weekly exposures to PM2.5 during pregnancy, allowing the

120 We used weekly fine-particulate-matter exposure data for 238 bir

121 against gastrointestinal AEs more than once-weekly folic acid, regardless of the total weekly dosage

122 of CSL830 per kilogram of body weight twice weekly followed by placebo, or vice versa.

123 and dietary portfolio principles (n = 145); weekly food provision reflecting this advice (n = 148);

124 , Ag(0), or Ag2S ENMs or soluble CuNO3 added weekly for 1 month.

125 onidin, malvidin and peonidin) were analyzed weekly for 15weeks in red- and purple-fleshed potato cul

126 administered for six 3-weekly cycles, then 4-weekly for 2 years.

127 Rats were given injections of paraquat once weekly for 3 weeks to induce features of Parkinsonism, o

128 All patients received rituximab 375 mg/m(2) weekly for 4 weeks, followed by a second course 1 month

129 received 60 mg MGN1703 subcutaneously twice weekly for 4 weeks.

130 Anthropometric measurements were taken weekly for 4 wk to monitor treatment response.

131 injections of exenatide 2 mg or placebo once weekly for 48 weeks in addition to their regular medicat

132 cise consisted of treadmill exercise 3 times weekly for 6 months.

133 individual sessions (135 participants) twice weekly for 6 weeks.

134 nously in week 1, then 1000 mg intravenously weekly for 7 weeks, and every 4 weeks for 16 weeks) or o

135 Daratumumab was administered at 16 mg/kg weekly for 8 weeks, then every 2 weeks for 8 doses, and

136 us pedometer-directed step targets, reviewed weekly for 8 wk).

137 eron beta-1a at a dose of 44 mug three times weekly for 96 weeks.

138 or 800 mg) or a multiple-dose phase (125 mg weekly for four doses, 250 mg every other week for two d

139 Household visits were made weekly for morbidity surveillance.

140 al function and drug concentrations occurred weekly for the first 3 months and were slowly tapered to

141 urine, saliva, semen, and vaginal secretions weekly for the first month and then at 2, 4, and 6 month

142 00 mg/m(2) as a 30-min intravenous infusion, weekly, for 7 weeks followed by a 1-week break, followed

143 me in the modern lifestyle, because both the weekly frequency and the weekly duration of exercise tim

144 Children were visited weekly from enrollment to age 9 months; the mother repor

145 samples (<150 ng/mL) three times a week and weekly gift cards for outpatient treatment attendance.

146 Weekly GOM in ambient air was predicted from measured we

147 Concurrent weekly Google-predicted influenza activity in the same c

148 3.0) for the trastuzumab emtansine 2.4 mg/kg weekly group and 15.4 months (9.2-18.1) in the taxane gr

149 [2%]) in the trastuzumab emtansine 2.4 mg/kg weekly group compared with pneumonia (four [4%]), febril

150 Weekly group sessions were facilitated by trained social

151 vents in the trastuzumab emtansine 2.4 mg/kg weekly group were anaemia (59 [26%]) and thrombocytopeni

152 .5 years of 6-monthly testing in the clinic, weekly home monitoring achieved this by 0.9 years despit

153 The improved performance of weekly home monitoring over 6-monthly clinical testing w

154 , India, and followed for 3 years with twice-weekly home visits.

155 e documented through clinic visits and twice-weekly house visits through 52 weeks.

156 Weekly i.n. GSK2245035 20 ng was well tolerated and redu

157 r 60 mg/m(2) with 20 mg dexamethasone, twice weekly in 28-day cycles, or selinexor (40 or 60 mg flat

158 0 mg ( approximately 35 mg/m(2)) given twice weekly in a 4-week cycle based on the totality of safety

159 to tildrakizumab; etanercept was given twice weekly in part 1 of reSURFACE 2 and once weekly during p

160 of failure (3.0; 95% CI, 1.0-8.8) with twice weekly in the continuation phase when compared with dail

161 ive anal intercourse (RAI; or at least twice weekly in the event of no RAI), or daily oral FTC/TDF.

162 up to 250 mg of peanut protein, followed by weekly increases up to 2000 mg.

163 Weekly influenza-test positive proportions for the eight

164 ; 7 consecutive cohorts, 0.3-100 mg/kg) or 4 weekly infusions (n = 16; 2 consecutive cohorts, 30 and

165 uximab according to the lymphoma protocol (4 weekly infusions of 375 mg/m2).

166 INTERPRETATION: Weekly infusions of rFIXFc were well tolerated and resul

167 Weekly injections of 1 mg kg(-1) of mRNA into immunodefi

168 ertib orally once daily with or without once-weekly injections of 125 mg of simtuzumab or simtuzumab

169 Furthermore, 3 weekly injections of HERV-K deoxyuridine triphosphate nu

170 ginning at 3 weeks of age, followed by twice-weekly injections until age 25 weeks, protects the anima

171 k would not exceed the provisional tolerable weekly intake (PTWI).

172 Our calculation suggests that probable weekly intake of mercury for local residents, assuming a

173 ples were collected by finger stick at twice-weekly intervals and tested with the Aptima assay.

174 The dose was increased at weekly intervals, from 0.5 mg to 3 mg/kg/day.

175 After 4 doses at weekly intervals, the survival period of the mice extend

176 for 3 sessions of measurements separated by weekly intervals.

177 were evaluated as time-varying covariates at weekly intervals.

178 atures were calculated from pretreatment and weekly intra-treatment computed tomography images for 10

179 ON: The MTD of Nexvax2 was 150 mug for twice weekly intradermal administration over 8 weeks, which mo

180 arginine deprivation (ADI-PEG20, 36.8 mg/m2, weekly intramuscular) plus best supportive care (BSC) or

181 nasal allergic reactivity following repeated weekly intranasal (i.n.) GSK2245035.

182 of girentuximab, 50 mg (week 1), followed by weekly intravenous infusions of girentuximab, 20 mg (wee

183 Participants received once-weekly isoniazid and rifapentine by direct observation,

184 pare treatment completion and safety of once-weekly isoniazid and rifapentine by self-administration

185 Once-weekly isoniazid and rifapentine for 12 doses is effecti

186 esults support using self-administered, once-weekly isoniazid and rifapentine to treat latent tubercu

187 (2) IV on days 1, 4, 8, and 11), followed by weekly IV bortezomib (1.6 mg/m(2) on days 1, 8, 15, and

188 first-line antenatal management in FNAIT is weekly IVIG administration, with or without the addition

189 ntervention group), including a website with weekly lessons, web diary, instructional videos, compute

190 ems have enabled safer drug rechallenge with weekly liver chemistry monitoring during the high-risk p

191 entrained simultaneously to two different bi-weekly lunar cycles with slightly different periods.

192 des of coupling of mood cycles to the two bi-weekly lunar cycles.

193 t of pornography use per week, and number of weekly masturbations.

194 ine platelet transfusions (IUPT), as well as weekly maternal IV immunoglobulin infusion (IVIG), with

195 M in ambient air was predicted from measured weekly mercury wet deposition using a scavenging ratio a

196 er, we found survival was most influenced by weekly minimum ambient temperatures.

197 weeks (4-weekly, n = 62) or every 8 weeks (8-weekly, n = 60).

198 mized to receive belatacept every 4 weeks (4-weekly, n = 62) or every 8 weeks (8-weekly, n = 60).

199 Weekly nasal mucus samples were analyzed for RVs, and re

200 MLE4901 significantly reduced the total weekly number of hot flushes by 45 percentage points (95

201 Weekly observation of ammonium over a twelve-year period

202 higher odds of SDCS when having sex at least weekly (odds ratio (OR) = 2.41, 95% confidence interval

203 ed treatment, received up to three cycles of weekly ofatumumab for 5 weeks.

204 ld strut healing was evaluated in vivo using weekly optical coherence tomography analysis.

205 Tocilizumab, received weekly or every other week, combined with a 26-week pred

206 bcutaneous tocilizumab (at a dose of 162 mg) weekly or every other week, combined with a 26-week pred

207 or other R/S variables (for >2 times/day vs. weekly or less, mortality rate ratio = 1.28, 95% confide

208 ted dose of trastuzumab emtansine (2.4 mg/kg weekly) or a taxane (same regimen as above).

209 ansine (3.6 mg/kg every 3 weeks or 2.4 mg/kg weekly) or physician's choice of a taxane (intravenous d

210 ndomized to receive oral methotrexate, 25 mg weekly, or oral mycophenolate mofetil, 1 g twice daily,

211 ed either Nexvax2 60 mug, 90 mug, or 150 mug weekly, or placebo over 15 days; in a fourth biopsy coho

212 r(s) was associated with lower odds of SDCS (weekly: OR = 0.64, 95% CI: 0.47, 0.85; monthly: OR = 0.6

213 monthly subcutaneous romosozumab (210 mg) or weekly oral alendronate (70 mg) in a blinded fashion for

214 Weekly oral ixazomib appears to be active in patients wi

215 We collected weekly oral swabs from young children and mothers in 32

216 iECG participants acquired iECGs twice weekly over 12 months (plus additional iECGs if symptoma

217 ingle injection or as 14 injections given bi-weekly over 26 weeks showed no vaccine related changes i

218 ollowing low oral rotenone doses given twice weekly over 50 weeks (half their lifespan).

219 Nexvax2 150 mug or 300 mug or placebo twice weekly over 53 days; in a third biopsy cohort, patients

220 An increase of 10 mug/m(3) in weekly ozone concentration was associated with a decreas

221 tion for 6 weeks followed by the addition of weekly paclitaxel for 12 weeks, followed by 3 cycles of

222 Here, we use eBird data to model weekly patterns of abundance and occurrence for 21 fores

223 The weekly percentage of specimens positive for RSV by PCR w

224 C57BL/6J mice received weekly periocular conjunctival fornix injections of a de

225 20 mug of teriparatide once daily plus oral weekly placebo or 35 mg of oral risedronate once weekly

226 We retrospectively tested weekly plasma samples from allogeneic HCT recipients at

227 ly placebo or 35 mg of oral risedronate once weekly plus daily injections of placebo for 24 months.

228 (HSV-2), and varicella zoster virus (VZV) by weekly polymerase chain reaction in plasma.

229 Groups received a 6-month, twice weekly programme.

230 PPVs) for advanced neoplasia were determined weekly, quarterly, and yearly.

231 treatment (three times weekly (tiw) or once weekly (qw)); placebo patients switched to tiw (DT); pat

232 3:1:3) to subcutaneous dupilumab 300 mg once weekly (qw), dupilumab 300 mg every 2 weeks (q2w), or pl

233 /kg every other week [Q2W] or 10 or 20 mg/kg weekly [QW] for 4 weeks and then Q2W thereafter [QW/Q2W]

234 This was in contrast to the impact of weekly random sampling (i.e., using saliva swabs) of at

235 ents in ten (34%) of 29 patients given twice-weekly recombinant human C1 esterase inhibitor, 13 (45%)

236 inhibitor (50 IU/kg; maximum 4200 IU) twice weekly, recombinant human C1 esterase inhibitor once wee

237 itor, 13 (45%) of 29 patients given the once-weekly regimen, and eight (29%) of 28 patients given pla

238 and causes less transaminase elevations, and weekly reminders may be an alternative when direct obser

239 The utility of weekly reminders was also evaluated in the 12-week regim

240 all 3 levels of salt intake, half-weekly and weekly rhythmical mineralocorticoid release promoted fre

241 Evidence existed for efficacy of weekly rifapentine-isoniazid regimens compared with no t

242 nth isoniazid (INH), 4-month rifampin (RIF), weekly rifapentine/isoniazid (RPT/INH) for 12 weeks, or

243 cumulative %RVP was closely correlated with weekly %RVP (R(2)=0.907) and was similarly associated wi

244 tional data set of plankton with 15 years of weekly samples encompassing c. 250 planktonic species fr

245 arctic Peninsula (WAP) with an approximately weekly sampling frequency was used to elucidate changes

246 3 home-monitoring (monthly, fortnightly, and weekly) schedules, each running over a 5-year period.

247 ral activation and completed an average of 6 weekly sessions.

248 tic use of a subcutaneous C1 inhibitor twice weekly significantly reduced the frequency of acute atta

249 Screening with twice-weekly single-lead iECG with remote interpretation in am

250 Conversely, weekly steroid treatment in mdx mice improved muscle fun

251 We prospectively collected serial weekly stool samples from 66 patients who underwent HCT,

252 All patients received weekly subcutaneous injections, with the active treatmen

253 oral placebo (n = 71; double-blind) or once-weekly subcutaneous semaglutide of 1.0 mg (n = 70) for 2

254 To evaluate the ability of a novel, weekly, subcutaneous buprenorphine depot formulation, CA

255 signed participants (2:2:1:1) to either once-weekly subcutaneously injected semaglutide (0.5 mg or 1.

256 Interestingly, twice-weekly supplementation of RANTES and eotaxin, chemokines

257 Applying weekly surveillance, clinical inspection alone was found

258 -severe AD, including 4 to 6 months of daily/weekly symptom and treatment use data, were evaluated (s

259 Menstrual patterns were assessed using a weekly text message link to an online survey inquiring a

260 thly monitoring, or self-administration with weekly text message reminders and monthly monitoring.

261 tailored, individual health coaching (twice-weekly text messages and telephone or video contacts eve

262 The CBT consisted of weekly therapist-guided sessions, with a maximum duratio

263 confidence interval [CI], 3.8-9.9) and twice weekly therapy in the continuation phase (7.3; 95% CI, 3

264 was significantly higher in arms with thrice weekly therapy throughout (6.8; 95% confidence interval

265 CRE were collected immediately before LT and weekly thereafter until hospital discharge.

266 rom patients at admission to the ICU or HDU, weekly thereafter, and at discharge.

267 (10.0; 95% CI, 2.1-46.7) in arms with thrice weekly throughout and higher rates of failure (3.0; 95%

268 MRQLQ scores were collected weekly throughout the study.

269 4 dosing schedules: daily throughout, thrice weekly throughout, daily (intensive phase) then thrice w

270 Weekly time-series water samples were collected from 3 u

271 rate of S aureus in health-care workers at 4-weekly timepoints was 36.9% (IQR 35.7-37.3), and 115 (58

272 )) continued original treatment (three times weekly (tiw) or once weekly (qw)); placebo patients swit

273 re measured until parasites cleared and then weekly to 63 days.

274 (starting dose 10 IU per day, then titrated weekly to a pre-breakfast self-measured plasma glucose t

275 ary analysis, the CHOP ROP model was applied weekly to predict the risk of ROP.

276 %RVP was derived for each weekly transmission.

277 pairs), and recipient dogs received up to 8 weekly treated transfusions from a single donor (a highl

278 The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patient

279 Headache (twice-weekly treatment) and nasopharyngitis (once-weekly treat

280 -weekly treatment) and nasopharyngitis (once-weekly treatment) were the most common adverse events.

281 Weekly treatments of mice with MN-anti-miR-10b and low-d

282 s for 15 consecutive weekdays, followed by 7 weekly treatments.

283 starting pre-transplantation and continuing weekly until 100 days post-transplant, a total of 694 ob

284 1) were obtained prior to NAM initiation and weekly until the end of treatment.

285 We show the performance of the weekly update pipeline since the release of ECOD, descri

286 ies on a combination of automatic and manual weekly updates to achieve its high accuracy and coverage

287 We compared weekly versus daily steroid treatment in mouse models of

288 or 0.4 g/kg of a 20% SCIg solution (IgPro20) weekly versus placebo (2% human albumin solution) for ma

289 ed from the coronal sulcus at baseline and 4 weekly visits after MC were assayed for pro-inflammatory

290 21.9%, and 13.9%, respectively (belatacept 4-weekly vs cyclosporine: HR = 1.06, 95% CI 0.35-3.17, P =

291 .06, 95% CI 0.35-3.17, P = .92; belatacept 8-weekly vs cyclosporine: HR = 2.00, 95% CI 0.75-5.35, P =

292 indicating that exenatide, administered once weekly, was noninferior to placebo with respect to safet

293 rmed after filter deployment from weeks 1-6 (weekly), weeks 7-20 (biweekly), and weeks 21-32 (monthly

294 -ROP (birth weight and gestational age, with weekly weight gain initiating examinations when the risk

295 ty evidence of benefit from adalimumab given weekly, while every other week dosing is ineffective, wi

296 The IV study drug was administered 3 times weekly with hemodialysis; the oral study drug was admini

297 Symptoms were assessed weekly with the Structured Interview Guide for the Hamil

298 heses were that exenatide, administered once weekly, would be noninferior to placebo with respect to

299 design was conducted initially with BV given weekly x 3 doses followed by maintenance dosing (initial

300 Participants received 12 weekly yoga classes, 15 PT visits, or an educational boo